Simeprevir: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
No edit summary
Turky Alkathery (talk | contribs)
Blanked the page
Line 1: Line 1:
__NOTOC__
{{Simeprevir}}
{{CMG}}


==Overview==
[[Medivir]] and [[Johnson & Johnson]]'s pharmaceutical division [[Janssen Pharmaceutica]].  In the United States, simeprevir is approved by the [[Food and Drug Administration]] for use in combination with[[peginterferon-alfa]] and [[ribavirin]].<ref>{{cite web | url = http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376449.htm | title = FDA approves new treatment for hepatitis C virus | publisher = [[Food and Drug Administration]] | date = Nov 22, 2013}}</ref>  Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.<ref>{{cite web | url = http://online.wsj.com/article/PR-CO-20130927-900120.html| title = Medivir: Simeprevir has been approved in Japan for the treatment of genotype 1 chronic hepatitis C infection | date = September 27, 2013 |publisher = The Wall Street Journal}}</ref>
==Category==
Antiviral
==US Brand Names==
OLYSIO<sup>®</sup>
==FDA Package Insert==
'''  [[Simeprevir description|Description]]'''
'''| [[Simeprevir clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Simeprevir microbiology|Microbiology]]'''
'''| [[Simeprevir indications and usage|Indications and Usage]]'''
'''| [[Simeprevir contraindications|Contraindications]]'''
'''| [[Simeprevir warnings and precautions|Warnings and Precautions]]'''
'''| [[Simeprevir adverse reactions|Adverse Reactions]]'''
'''| [[Simeprevir drug interactions|Drug Interactions]]'''
'''| [[Simeprevir overdosage|Overdosage]]'''
'''| [[Simeprevir clinical studies|Clinical Studies]]'''
'''| [[Simeprevir dosage and administration|Dosage and Administration]]'''
'''| [[Simeprevir how supplied|How Supplied]]'''
'''| [[Simeprevir labels and packages|Labels and Packages]]'''
==Mechanism of Action==
==References==
{{Reflist|2}}
[[Category:Antiviral]]
[[Category:Wikinfect]]

Revision as of 13:41, 19 March 2015